newsfilter
← Latest News
PR Newswire·

QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations

  • QuidelOrtho Corporation appointed Sanjeev Sharma as Vice President, Investor Relations effective September 28, 2026.
  • Sharma holds over 20 years of experience in investor relations, corporate strategy, & equity research at global organizations.
  • He previously served as Senior Director of Investor Relations at Teva Pharmaceuticals during a period of significant transformation.
  • Prior to Teva, Sharma spent over a decade in progressively senior roles at Genpact & nearly six years in sell-side equity research.
  • Sharma holds a master's degree in finance & is a Chartered Financial Analyst (CFA).
  • CFO Micah Young stated Sharma's healthcare experience & capital markets perspective will help sharpen communications & deepen shareholder engagement.
  • Sharma expressed excitement to join QuidelOrtho to partner with leadership on strategic priorities & long-term value creation.